CompuMed (OTCMKTS:CMPD) Stock Price Up 1.5% – Should You Buy?

CompuMed Inc. (OTCMKTS:CMPD) shares rose 1.5% during trading on Wednesday . The company traded as high as $6.00 and last traded at $6.00. Approximately 310 shares traded hands during trading, a decline of 82% from the average session volume of 1,719 shares. The stock had previously closed at $5.91.

CompuMed Price Performance

The firm has a market capitalization of $7.98 million, a PE ratio of -40.00 and a beta of -0.48. The company has a current ratio of 2.37, a quick ratio of 2.34 and a debt-to-equity ratio of 0.12. The company has a fifty day moving average price of $6.26 and a two-hundred day moving average price of $6.01.

CompuMed (OTCMKTS:CMPD) last released its quarterly earnings results on Monday, May 11th. The company reported ($0.06) earnings per share (EPS) for the quarter. The firm had revenue of $2.03 million for the quarter. CompuMed had a negative return on equity of 6.47% and a negative net margin of 2.51%.

CompuMed Company Profile

CompuMed, Inc, an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults.